Page last updated: 2024-08-18

dimethyldioctadecylammonium and Respiratory Syncytial Virus Infections

dimethyldioctadecylammonium has been researched along with Respiratory Syncytial Virus Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck, A; Bonnefoy, JY; Bussat, MC; Corvaïa, N; Klinguer-Hamour, C; Libon, C; Nguyen, T; Plotnicky-Gilquin, H; Revy, L	1

Other Studies

1 other study(ies) available for dimethyldioctadecylammonium and Respiratory Syncytial Virus Infections

Article	Year
DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine. Vaccine, 2002, Jun-21, Volume: 20, Issue:21-22 Topics: Adjuvants, Immunologic; Animals; Female; Interferon-gamma; Interleukin-4; Interleukin-5; Mice; Mice, Inbred BALB C; Quaternary Ammonium Compounds; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Sigmodontinae; Th1 Cells; Th2 Cells; Vaccines, DNA; Viral Proteins	2002

Article

Year

DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine.

Vaccine, 2002, Jun-21, Volume: 20, Issue:21-22

Topics: Adjuvants, Immunologic; Animals; Female; Interferon-gamma; Interleukin-4; Interleukin-5; Mice; Mice, Inbred BALB C; Quaternary Ammonium Compounds; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Sigmodontinae; Th1 Cells; Th2 Cells; Vaccines, DNA; Viral Proteins

2002